Back to MW Marshall Wace, LLP

RMTIRMTI
10 quarters

Position history for MWMarshall Wace, LLP's holdings in Rockwell Medical, Inc.

No. Marshall Wace exited its RMTI (Rockwell Medical) position in Q3 2025. Its Q2 2025 13F listed 173,779 shares worth $147,713. Marshall Wace first reported RMTI in Q2 2023 and held it in 8 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$87,943

Total Shares Change

-16,107

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%$12.00
0
2025-Q2
Decreased
173,779
-47.9%
$147,7130.0%$8.50
0
2025-Q1
Decreased
333,595
-44.1%
$376,9620.0%$11.30
0
2024-Q4
Increased
596,359
+17.2%
$1.2M0.0%$20.40
29
2024-Q3
New
508,674
-
$2M0.0%$39.70
36
2024-Q2
Exited
0
-100.0%
$00.0%$17.60
0
2024-Q1
Decreased
97,828
-44.1%
$162,3950.0%$16.60
0
2023-Q4
Decreased
175,096
-27.6%
$330,9320.0%$18.90
0
2023-Q3
Increased
241,901
+1401.8%
$503,1540.0%$20.80
39
2023-Q2
New
16,107
-
$87,9430.0%$54.60
30

Other major holders of RMTI: Vanguard Group Inc., Renaissance Technologies LLC, Jane Street Group, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used